Appearance | Creamish to white powder |
Purity / Analysis Method | 99.67% (HPLC) |
Los on drying | NMT 0.5% |
Water | NMT 4.5 – 6.0% |
Sulphated Ash | NMT 0.2% |
Solubility | Soluble in Water |
Teneligliptin Hbr.
Teneligliptin (hydrobromide hydrate); 3-[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine, hydrobromide, hydrate, [(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinylmethanone, hydrobromide (1:x), hydrate (1:x), [(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-yl](1,3-thiazolidin-3-yl)methanone, hydrobromide, hydrate;
Purity / Analysis Method | 98.0% – 102.0% (HPLC) |
Molecular Formula / Molecular Weight | C22H30N6OS · 2.5HBr · yH2O = 426.6 |
Physical State (20 deg.C) | Solid |
CAS RN | 1572583-29-9 |
Unit | Price |
1 g | 7500 |
5 g | 17000 |
10 g | 25500 |
Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
---|